implantcast is very well-known in Europe, but has not been approved by the U.S. Food and Drug Administration for wide-spread use in the United States. Hence, each case must be approved by the FDA on a case-by-case basis.
Dr. Buch focuses on orthopedic revisions and orthopedic oncology and is the only surgeon who has been approved to use any of the company’s implants in the United States.
“This is a big day for Dallas Medical Center,” said Raji Kumar, CEO of Dallas Medical Center. “We are lucky to have Dr. Buch on staff here as our Director of Orthopedics as someone who is willing to push the envelope to save someone’s arm, who otherwise would have had no choice but to amputate.”
More articles on orthopedics:
15 sports medicine physicians on the move
Dr. William Mason joins Salisbury Orthopaedic Associates
Dr. Shapiro establishes sports medicine practice at Kennedy-White Orthopaedic Center
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
